Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
US8389518B2 · kind B2 · utility
13Cited by
4References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 20, 2008 |
| Grant date | Mar 5, 2013 |
| Priority date | — |
| Expiry date | May 8, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.